These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35062313)

  • 21. Sodium Copper Chlorophyllin Is Highly Effective against Enterovirus (EV) A71 Infection by Blocking Its Entry into the Host Cell.
    Liu Z; Xia S; Wang X; Lan Q; Li P; Xu W; Wang Q; Lu L; Jiang S
    ACS Infect Dis; 2020 May; 6(5):882-890. PubMed ID: 32233455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo.
    Cao Y; Lei E; Wang X; Qi X; Li L; Ren J; Yang J; Wang S
    Antiviral Res; 2021 Nov; 195():105091. PubMed ID: 34044060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis.
    Too IHK; Bonne I; Tan EL; Chu JJH; Alonso S
    PLoS Pathog; 2018 Jan; 14(1):e1006778. PubMed ID: 29324904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validating Enterovirus D68-2A
    Musharrafieh R; Ma C; Zhang J; Hu Y; Diesing JM; Marty MT; Wang J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway.
    Yang Q; Wu C; Zhu G; Ren F; Lin B; Huang R; Hu X; Zhao D; Peng K; Wu Y; Wang Q; Huang C; Zhang D
    Antiviral Res; 2023 Jan; 209():105498. PubMed ID: 36563943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71.
    Chen TC; Chang HY; Lin PF; Chern JH; Hsu JT; Chang CY; Shih SR
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2740-7. PubMed ID: 19414569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
    Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
    Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease.
    Liu M; Xu B; Ma Y; Shang L; Ye S; Wang Y
    Antiviral Res; 2021 Aug; 192():105102. PubMed ID: 34082057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine is a potent inhibitor of coxsackievirus replication.
    Zuo J; Quinn KK; Kye S; Cooper P; Damoiseaux R; Krogstad P
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4838-44. PubMed ID: 22751539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient Blocking of Enterovirus 71 Infection by Heparan Sulfate Analogues Acting as Decoy Receptors.
    Earley DF; Bailly B; Maggioni A; Kundur AR; Thomson RJ; Chang CW; von Itzstein M
    ACS Infect Dis; 2019 Oct; 5(10):1708-1717. PubMed ID: 31307190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
    Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
    J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combating enterovirus replication: state-of-the-art on antiviral research.
    Thibaut HJ; De Palma AM; Neyts J
    Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of 2'-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents.
    Yan L; Cao R; Zhang H; Li Y; Li W; Li X; Fan S; Li S; Zhong W
    Eur J Med Chem; 2021 Dec; 226():113852. PubMed ID: 34560428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnolol against enterovirus 71 by targeting Nrf2-SLC7A11-GSH pathway.
    Zhao D; Guo X; Lin B; Huang R; Li H; Wang Q; Zeng Y; Shang Y; Wu Y
    Biomed Pharmacother; 2024 Jul; 176():116866. PubMed ID: 38876045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug discovery in enteroviral infections.
    Chen TC; Shih SR
    Infect Disord Drug Targets; 2011 Jun; 11(3):337-45. PubMed ID: 21488833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.
    Bauer L; Manganaro R; Zonsics B; Hurdiss DL; Zwaagstra M; Donselaar T; Welter NGE; van Kleef RGDM; Lopez ML; Bevilacqua F; Raman T; Ferla S; Bassetto M; Neyts J; Strating JRPM; Westerink RHS; Brancale A; van Kuppeveld FJM
    PLoS Biol; 2020 Nov; 18(11):e3000904. PubMed ID: 33156822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of EV71 by curcumin in intestinal epithelial cells.
    Huang HI; Chio CC; Lin JY
    PLoS One; 2018; 13(1):e0191617. PubMed ID: 29370243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of antiviral agents toward enterovirus 71 infection.
    Pourianfar HR; Grollo L
    J Microbiol Immunol Infect; 2015 Feb; 48(1):1-8. PubMed ID: 24560700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway.
    Lv X; Qiu M; Chen D; Zheng N; Jin Y; Wu Z
    Antiviral Res; 2014 Sep; 109():30-41. PubMed ID: 24971492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 14S-(2'-chloro-4'-nitrophenoxy)-8R/S,17-epoxy andrographolide as EV-A71 infection inhibitor.
    Dai K; Tan JK; Qian W; Lee RCH; Hann Chu JJ; Zhou GC
    Biochem Pharmacol; 2021 Dec; 194():114820. PubMed ID: 34748818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.